Antibodies Market is Forecast to Reach a Valuation of US$ 601.614 Billion by the end of 2031 | Future Market Insights, Inc.

The U.S. is the leading manufacturer of antibodies owing to modern healthcare infrastructural facilities and presence of leading market players in the country. Increasing purchasing power of consumers along with increasing government funding will drive the market growth. GCC countries led by Saudi Arabia is emphasizing on early diagnosis and screening of cancer to elevate the survival rate and chance of successful treatment. Indian antibodies market is anticipated to grow at a rapid pace owing to rising cases of cancer and cardiovascular diseases along with development of healthcare system in the country

Valley Cottage, New York, UNITED STATES


NEWARK, Del, Aug. 18, 2022 (GLOBE NEWSWIRE) -- According to Future Market Insights, a leading market research and competitive intelligence provider, the antibodies market will grow at a 21x pace in upcoming decades, surpassing US$ 601.614 Billion by the end of 2031.

As per FMI studies, the leading players in the antibodies market include F. Hoffmann-La Roche Ltd., AbbVie Inc., Johnson & Johnson Services, Inc., Amgen Inc., and Bristol-Myers Squibb Company. These key players together account for 3 out of 4 sales of antibodies across the globe.

According to the reports of the National Stem Foundation (NSCF), about 4% of the global population is affected by some sort of autoimmune disease. The most common autoimmune diseases are diabetes, multiple sclerosis, Crohn’s disease, and rheumatoid arthritis. Due to these chronic diseases, the demand for antibodies market is estimated through the roof.

Request a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1330

Key Insights

Antibodies are essential for treating medical conditions including autoimmune diseases, cancer, and several types of neurological diseases. Immunoglobulin (IG) is a type of antibody that is used for the prevention of lower respiratory tract infections and diseases caused by the vaccinia virus. Rising cases of viral infection will drive the demand for antibodies.

The prevalence of autoimmune diseases is on the rise, and they also have the potential to act as a host for multiple chronic ailments. Owing to these factors, the demand for antibodies is forecast to increase in upcoming years.

The COVID-19 pandemic boosted the demand for antibodies as patients suffering from COVID-19 were highly susceptible to contracting various other ailments and, in some cases, triggered autoimmune diseases in the patient.

Novel biosimilar antibody manufacturers are slashing their prices to compete with branded antibody manufacturers, especially in the European market. With the expiration of patents of renowned products, a boost in demand for biosimilar antibodies can be expected in upcoming years.

A reasonable hike in research and development activities among healthcare and pharmaceutical market leaders are working towards developing effective and economical antibodies and biosimilar antibodies, propelling growth in the market.

Parkinson's and Sclerosis diseases are on the rise among older people which is a key factor fueling the demand for antibodies. There is an urgency to develop cheap and personalized medicines, novel and effective treatments, and advanced therapeutics in middle-income countries which is expected to positively influence the sales of antibodies.

The widespread application of antibodies in chronic disease treatment is accelerating which is predicted to create scope for market expansion in the near future.

Competitive Landscape

Novartis AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi SA, Eli Lilly, and Co. are some of the key companies profiled in the full version of the report.

Future Market Insights (FMI) has found that market players are working towards developing new antibodies to treat cancer and other diseases. They are also researching to create long-acting antibody drugs to reduce healthcare costs.

In order to gain a competitive edge in the antibodies market, key players are developing oral and noninvasive treatments using antibodies to treat chronic ailments. Strategic mergers and acquisitions for portfolio expansion are in the cards as well.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1330

More Insights into Antibodies Market

The United States is considered the dominant market in the North American region owing to modern healthcare infrastructural facilities and the presence of leading market players in the country. An increase in government funding and elevated purchasing power is expected to drive growth in the market.

The GCC countries led by Saudi Arabia are increasingly focusing on research and development on early diagnosis and screening of cancer to elevate the survival rate and chance of successful treatment. The contribution of antibodies is significant in this research. Hence, propelling growth in the market.

The development and production of antibodies are on a rise in China and are expected to surge significantly owing to increasing government investment in drugs and development coupled with growing awareness about various medical ailments like rheumatoid arthritis, cancer, and infections.

The Indian antibodies market is anticipated to grow at a rapid pace owing to rising cases of cancer and cardiovascular diseases along with the development of the healthcare system in the country. According to the reports of the Global Cancer Observatory, 1.322 million new cancer cases were registered in India in 2020, while 2.72 million people had cancer for 5 years. A surge in cancer patients will drive the demand for monoclonal antibodies for cancer treatment.

Key Segments Covered in Antibodies Market Study

By Disease Indication

  • Cardiovascular diseases
  • CNS disorders
  • Cancer
  • Autoimmune Disorders

By Product Type

  • Monoclonal antibodies
  • Polyclonal antibodies
  • Antibody-drug complexes (ADCs) 

By End User

  • Hospitals
  • Long-term Care Facilities
  • Research institutes

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa (MEA)

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1330

Table of Content

1. Executive Summary

2. Assumptions and Acronyms

3. Research Methodology

4. Antibodies Market Overview

4.1. Introduction

4.1.1. Antibodies Market Definition

4.1.2. Antibodies Market Taxonomy

4.1.3. Antibodies Market Product Type Overview

4.1.4. Overview

4.2. Antibodies Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunity

4.3. Regulations

5. Global Antibodies Market Forecast

5.1. Market Value (US$ Mn) Forecast

5.1.1. Y-o-Y Growth Projections

5.1.2. Absolute $ Opportunity

5.2. Antibodies Market Trends

5.2.1. Market Share, By Region

5.2.2. Market Share, By Product Type

5.2.3. Market Share, By End User

5.2.4. Market Share, By Disease Indication

Get detailed TOC @ https://www.futuremarketinsights.com/toc/rep-gb-1330

Have a Look at Related Research Reports of Healthcare

Antibody Therapy Market Size is expected to reach US$ 727.78 Bn in 2032, with a favorable rate of 13.2% during the forecast period

Antibody Pair Kits Market Share is likely to register a CAGR of 7.7% during the forecast period, and is anticipated to reach a market share of US$ 18.04 Bn in 2032, from US$ 7.4 Bn in 2021

Antibody Isotyping Kits Market Demand is likely to attain 11% CAGR during the forecast period 2022-2032

Antibody Purification Service Market Growth is expected to pace up and flourish at a significant rate during the forecast period 2020-2030

Anti Neurofilament L Antibody Market Forecast is anticipated to showcase an incremental growth rate from 2022-2032 with an estimated CAGR of 11%. The anti-neurofilament L antibody market is likely to rise from US$ 145 Bn in 2022 to US$ 457 Bn by 2032

Antinuclear Antibody Test Market Trends is currently valued at US$ 7.4 Bn in 2022 and is likely to reach US$ 17.25 Bn by 2032

Bispecific Antibody Market Outlook was established there has been exponential growth in terms of revenue generation

Human combinatorial antibody libraries (HuCAL) Market Size is growing significantly with the research advancements, emerging companies, government aid and investments

Nasal Packing Devices Market Share is expected to reach a market valuation of US$ 182.03 Million by the year 2022, accelerating with a moderate CAGR of 5.1% by 2022-2032

Transcranial Doppler Ultrasounds System Market Demand is likely to reach a revenue of about US$ 658.4 million by 2032, up from US$ 299.2 million in 2022 moving forward with a CAGR of 7.4% during the forecast period

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.  

Contact

Future Market Insights Inc.   
Christiana Corporate, 200 Continental Drive, 
Suite 401, Newark, Delaware - 19713, USA   
T: +1-845-579-5705   
Report: https://www.futuremarketinsights.com/reports/antibodies-market
For Sales Enquiries: sales@futuremarketinsights.com    
Browse latest Market Reports: https://www.futuremarketinsights.com/reports 
LinkedIn| Twitter| Blogs